tirzepatide in fridge TrimRX 5ml Peptide Storage Box (

GLP-1 receptor agonists reduce all-cause mortality and major adverse cardiovascular events (MACE) by approximately 1213% in high-risk populations, as detailed in this 2025 review of cardiovascular effects of GLP-1 receptor agonists on PubMed

5c and d)

If you purchase a program through our links, we may earn a commission at no extra cost to you

The GLP-1 agonists market is projected to experience strong growth during the forecast period, propelled by ongoing advances in drug delivery technologies and the increasing adoption of GLP-1 therapies for diabetes and obesity management

While hypoglycaemia is rare with Wegovy monotherapy, the risk increases when combined with insulin or sulfonylureas